Avanafil: Phase II data

In a double-blind, placebo-controlled, crossover Phase II study in 101 healthy males who received sublingual 0.4 mg glyceryl trinitrate (GTN),

Read the full 201 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE